Warfarin Dose Adjustment for INR 1.5
Increase your weekly warfarin dose by 10-15% and recheck INR in 1-2 weeks. Given your current regimen (32.5 mg/week) and the drop from INR 2.0 to 1.5, you need a modest dose increase to return to therapeutic range.
Recommended Dosing Strategy
Your current weekly dose is 32.5 mg (5 mg × 5 days + 2.5 mg × 2 days). A 10-15% increase means adding approximately 3.25-5 mg per week.
Practical adjustment options:
- Option 1: Change Tuesday and Thursday from 2.5 mg to 5 mg (increases weekly dose to 42.5 mg, a 31% increase - more aggressive)
- Option 2: Add 2.5 mg on one additional day per week (increases to 35 mg weekly, an 8% increase - more conservative)
- Option 3: Change one of the 2.5 mg days to 3.75 mg (split a 2.5 mg and 2.5 mg tablet) for a 12% increase
I recommend Option 2 or 3 as they provide the 10-15% increase that aligns with evidence-based practice 1.
Rationale for This Approach
The 2012 ACCP guidelines address this exact scenario. While they suggest that a single out-of-range INR of 0.5 below therapeutic (INR 1.5 when target is 2.0-3.0) could be managed by continuing the same dose 1, your situation involves a declining trend (from INR 2.0 to 1.5), which warrants dose adjustment rather than watchful waiting.
The guideline's recommendation to continue the same dose applies specifically to patients with "previously stable therapeutic INRs" experiencing an isolated deviation 1. Your INR has dropped from therapeutic to subtherapeutic, indicating inadequate anticoagulation that requires correction.
Important Considerations
Recheck timing: Obtain repeat INR in 1-2 weeks after dose adjustment 1. Warfarin's pharmacodynamics mean changes take several days to manifest fully, with an effective half-life of 20-60 hours 2.
No bridging needed: Despite the subtherapeutic INR, bridging with heparin is not recommended for a single low INR in stable patients 1. The absolute daily risk of thromboembolism remains low.
Investigate causes: Before adjusting, consider:
- Recent dietary changes (increased vitamin K intake)
- New medications (CYP2C9 inducers like rifampin, carbamazepine can significantly lower INR) 3
- Missed doses
- Changes in health status
Monitoring After Adjustment
Once you make the dose change:
- Recheck INR in 7-14 days
- If INR returns to 2.0-3.0 range, continue new dose and recheck in 2-4 weeks
- If INR remains low, consider further 10-15% increase
- Once stable in therapeutic range for 3+ consecutive measurements, you can extend monitoring intervals up to 12 weeks 1
Safety Note
An INR of 1.5 carries increased thrombotic risk but does not require emergency intervention. The goal is to return to the therapeutic range of 2.0-3.0, which balances stroke/thrombosis prevention against bleeding risk 2. Avoid overcorrection - excessive increases can lead to supratherapeutic INRs (>4.0) which significantly increase bleeding risk 4.